Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
Condition(s):Alcoholic Fatty Liver Disease; Alcoholic HepatitisLast Updated:April 29, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Alcoholic Fatty Liver Disease; Alcoholic HepatitisLast Updated:April 29, 2015Completed
Condition(s):Critical Limb Ischemia; Peripheral Arterial DiseaseLast Updated:August 9, 2018Unknown status
Condition(s):Healthy Adult SubjectsLast Updated:January 14, 2014Completed
Condition(s):Anemia, Iron-DeficiencyLast Updated:July 19, 2018Completed
Condition(s):NAFLDLast Updated:December 11, 2023Recruiting
Condition(s):Colorectal Cancer; Chemotherapy-induced Peripheral NeuropathyLast Updated:December 17, 2021Terminated
Condition(s):Crow’s Feet WrinklesLast Updated:April 8, 2016Completed
Condition(s):Insulin Resistance; Obesity; Cardiovascular Diseases; Cognitive Impairment; Physical Disability; Depression; Inflammation; Hormone Deficiency; Physical Inactivity; Hyperlipidemias; Hypertension; OvereatingLast Updated:February 6, 2024Recruiting
Condition(s):Advanced Metastatic (Stage IV) Colorectal CancerLast Updated:July 6, 2018Completed
Condition(s):Acute Non-specific Low Back PainLast Updated:October 6, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.